136 related articles for article (PubMed ID: 12708818)
21. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.
Novoselac AV; Reddy S; Sanmugarajah J
Leukemia; 2004 Sep; 18(9):1561-2. PubMed ID: 15215874
[No Abstract] [Full Text] [Related]
22. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F
Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610
[TBL] [Abstract][Full Text] [Related]
23. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.
Sadiq SA; Rammal M; Sara G
Mult Scler; 2008 Mar; 14(2):272-3. PubMed ID: 17986509
[TBL] [Abstract][Full Text] [Related]
25. Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients.
Voltz R; Starck M; Zingler V; Strupp M; Kolb HJ
Mult Scler; 2004 Aug; 10(4):472-4. PubMed ID: 15327049
[TBL] [Abstract][Full Text] [Related]
26. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia.
Cartwright MS; Jeffery DR; Lewis ZT; Koty PP; Stewart WT; Molnár I
Neurology; 2007 May; 68(19):1630-1. PubMed ID: 17485652
[No Abstract] [Full Text] [Related]
27. Mitoxantrone-related acute myelocytic leukemias.
Hossfeld DK
Ann Oncol; 2000 Oct; 11(10):1215-6. PubMed ID: 11106108
[No Abstract] [Full Text] [Related]
28. Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosis.
Mulroy E; Joyce E; Scott J; Melling J; Goggin C; Mahon N; O'Rourke K; Lynch T
Eur Neurol; 2012; 67(1):45-7. PubMed ID: 22156316
[TBL] [Abstract][Full Text] [Related]
29. Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
Killestein J; van der Meer ML; Regelink JC; Huijgens PC; Polman CH
Neurology; 2010 Mar; 74(11):934; author reply 934. PubMed ID: 20231672
[No Abstract] [Full Text] [Related]
30. Acute myeloid leukaemia induced by mitoxantrone: case report.
Arruda WO; Montú MB; de Oliveira Mde S; Ramina R
Arq Neuropsiquiatr; 2005 Jun; 63(2A):327-9. PubMed ID: 16100984
[TBL] [Abstract][Full Text] [Related]
31. Mitoxantrone in the treatment of multiple sclerosis.
Morrissey SP; Le Page E; Edan G
Int MS J; 2005 Nov; 12(3):74-87. PubMed ID: 16417821
[TBL] [Abstract][Full Text] [Related]
32. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
33. [Mitoxantrone].
Pericot I; Montalban X
Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
[TBL] [Abstract][Full Text] [Related]
34. Mitoxantrone in multiple sclerosis.
Neuhaus O; Kieseier BC; Hartung HP
Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
[No Abstract] [Full Text] [Related]
35. [Mitoxantrone, a new reality].
Ruiz-Peña JL; Izquierdo G
Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055
[No Abstract] [Full Text] [Related]
36. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
[TBL] [Abstract][Full Text] [Related]
37. [Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].
Nollet S; Berger E; Deconinck E; Baldauf E; Rumbach L
Rev Neurol (Paris); 2006 Feb; 162(2):195-9. PubMed ID: 16518259
[TBL] [Abstract][Full Text] [Related]
38. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis.
Ghalie RG; Mauch E; Edan G; Hartung HP; Gonsette RE; Eisenmann S; Le Page E; Butine MD; De Goodkin DE
Mult Scler; 2002 Oct; 8(5):441-5. PubMed ID: 12356214
[TBL] [Abstract][Full Text] [Related]
39. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
40. [Mitoxanthrone in the therapy of multiple sclerosis].
Kieseier BC; Gold R; Hartung HP
Nervenarzt; 2003 Oct; 74(10):906-10. PubMed ID: 14551698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
